Examining the Therapist's Internal Experience When a Patient Dissociates in Session
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mapping the Dissociated Body
Lesley University DigitalCommons@Lesley Graduate School of Arts and Social Sciences Expressive Therapies Capstone Theses (GSASS) Spring 5-16-2020 Mapping the Dissociated Body Elizabeth Hough [email protected] Follow this and additional works at: https://digitalcommons.lesley.edu/expressive_theses Part of the Social and Behavioral Sciences Commons Recommended Citation Hough, Elizabeth, "Mapping the Dissociated Body" (2020). Expressive Therapies Capstone Theses. 239. https://digitalcommons.lesley.edu/expressive_theses/239 This Thesis is brought to you for free and open access by the Graduate School of Arts and Social Sciences (GSASS) at DigitalCommons@Lesley. It has been accepted for inclusion in Expressive Therapies Capstone Theses by an authorized administrator of DigitalCommons@Lesley. For more information, please contact [email protected], [email protected]. Running Head: MAPPING THE DISSOCIATED BODY 1 Mapping the Dissociated Body Elizabeth Hough Lesley University Running Head: MAPPING THE DISSOCIATED BODY 2 Abstract This capstone thesis explored the use of body mapping and body scans as a tool for assessing and tracking somatic dissociation and embodiment. The researcher utilized a client- centered approach and mindfulness-based interventions and theory to ground the work with the clients. While there were a variety of questionnaire-based tools for assessing dissociation with clients, many of them were lacking in the somatic component of dissociation. The available assessments were also exclusively self-reported and written or verbal, which had the potential to result in biased reporting. Clients may have also struggled to identify their level of somatic dissociation due to an inherent disconnection or dismissal of their somatic experience. This research described two case studies in which body scans and body mapping were utilized as a method to assess and track the client’s level of body dissociation and embodiment. -
UC Riverside UC Riverside Electronic Theses and Dissertations
UC Riverside UC Riverside Electronic Theses and Dissertations Title Sonic Retro-Futures: Musical Nostalgia as Revolution in Post-1960s American Literature, Film and Technoculture Permalink https://escholarship.org/uc/item/65f2825x Author Young, Mark Thomas Publication Date 2015 Peer reviewed|Thesis/dissertation eScholarship.org Powered by the California Digital Library University of California UNIVERSITY OF CALIFORNIA RIVERSIDE Sonic Retro-Futures: Musical Nostalgia as Revolution in Post-1960s American Literature, Film and Technoculture A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in English by Mark Thomas Young June 2015 Dissertation Committee: Dr. Sherryl Vint, Chairperson Dr. Steven Gould Axelrod Dr. Tom Lutz Copyright by Mark Thomas Young 2015 The Dissertation of Mark Thomas Young is approved: Committee Chairperson University of California, Riverside ACKNOWLEDGEMENTS As there are many midwives to an “individual” success, I’d like to thank the various mentors, colleagues, organizations, friends, and family members who have supported me through the stages of conception, drafting, revision, and completion of this project. Perhaps the most important influences on my early thinking about this topic came from Paweł Frelik and Larry McCaffery, with whom I shared a rousing desert hike in the foothills of Borrego Springs. After an evening of food, drink, and lively exchange, I had the long-overdue epiphany to channel my training in musical performance more directly into my academic pursuits. The early support, friendship, and collegiality of these two had a tremendously positive effect on the arc of my scholarship; knowing they believed in the project helped me pencil its first sketchy contours—and ultimately see it through to the end. -
XELJANZ (Tofacitinib)
HIGHLIGHTS OF PRESCRIBING INFORMATION Psoriatic Arthritis (in combination with nonbiologic DMARDs) These highlights do not include all the information needed to use XELJANZ 5 mg twice daily or XELJANZ XR 11 mg once daily. (2.2) XELJANZ/XELJANZ XR safely and effectively. See full prescribing Recommended dosage in patients with moderate and severe renal information for XELJANZ. impairment or moderate hepatic impairment is XELJANZ 5 mg once daily. (2, 8.7, 8.8) ® XELJANZ (tofacitinib) tablets, for oral use Ulcerative Colitis ® XELJANZ XR (tofacitinib) extended-release tablets, for oral use XELJANZ 10 mg twice daily for at least 8 weeks; then 5 or 10 mg Initial U.S. Approval: 2012 twice daily. Discontinue after 16 weeks of 10 mg twice daily, if adequate therapeutic benefit is not achieved. Use the lowest effective dose to WARNING: SERIOUS INFECTIONS AND MALIGNANCY maintain response. (2.3) See full prescribing information for complete boxed warning. Recommended dosage in patients with moderate and severe renal impairment or moderate hepatic impairment: half the total daily dosage Serious infections leading to hospitalization or death, including recommended for patients with normal renal and hepatic function. (2, 8.7, tuberculosis and bacterial, invasive fungal, viral, and other 8.8) opportunistic infections, have occurred in patients receiving Dosage Adjustment XELJANZ. (5.1) See the full prescribing information for dosage adjustments by indication If a serious infection develops, interrupt XELJANZ/XELJANZ XR for patients receiving CYP2C19 and/or CYP3A4 inhibitors; in patients until the infection is controlled. (5.1) with moderate or severe renal impairment or moderate hepatic Prior to starting XELJANZ/XELJANZ XR, perform a test for latent impairment; and patients with lymphopenia, neutropenia, or anemia. -
Challenges and Potential Benefits of Mind Wandering in Education
Scholarship of Teaching and Learning in Psychology © 2016 American Psychological Association 2016, Vol. 2, No. 2, 134–146 2332-2101/16/$12.00 http://dx.doi.org/10.1037/stl0000060 TEACHER-READY THEORY REVIEW The Mind That Wanders: Challenges and Potential Benefits of Mind Wandering in Education Amy A. Pachai, Anita Acai, Andrew B. LoGiudice, and Joseph A. Kim McMaster University Our minds naturally wander for much of our daily lives. Here we review how mind wandering, or task-unrelated thought, impacts comprehension during lectures and reading, and how it relates to general academic success. In some situations, mind wandering may not hinder performance, and may even aid in creativity, future plan- ning, problem solving, and relief from boredom. We distill research on the negative and potentially positive effects of mind wandering to suggest ways that teachers can reduce and redirect mind wandering in the classroom. To conclude we suggest that, rather than attempt to eliminate mind wandering entirely, we should attempt to alleviate mind wandering at the most strategic times, using research to suggest what techniques should be applied, and when. Keywords: mind wandering, learning, focused attention, education It is unreasonable to expect students to gelhardt, & Kingstone, 2012; Smallwood, continuously pay attention while listening to a Obonsawin, & Reid, 2002; Szpunar, Khan, & lecture, reading a textbook, or studying for a Schacter, 2013), making lengthy lectures or test. The mind naturally wanders, shifting at- study sessions even more problematic. A re- tention from the primary learning task at hand cent surge in mind wandering research has to internal, personally relevant thoughts produced findings relevant to educators. -
1: Gastro-Intestinal System
1 1: GASTRO-INTESTINAL SYSTEM Antacids .......................................................... 1 Stimulant laxatives ...................................46 Compound alginate products .................. 3 Docuate sodium .......................................49 Simeticone ................................................... 4 Lactulose ....................................................50 Antimuscarinics .......................................... 5 Macrogols (polyethylene glycols) ..........51 Glycopyrronium .......................................13 Magnesium salts ........................................53 Hyoscine butylbromide ...........................16 Rectal products for constipation ..........55 Hyoscine hydrobromide .........................19 Products for haemorrhoids .................56 Propantheline ............................................21 Pancreatin ...................................................58 Orphenadrine ...........................................23 Prokinetics ..................................................24 Quick Clinical Guides: H2-receptor antagonists .......................27 Death rattle (noisy rattling breathing) 12 Proton pump inhibitors ........................30 Opioid-induced constipation .................42 Loperamide ................................................35 Bowel management in paraplegia Laxatives ......................................................38 and tetraplegia .....................................44 Ispaghula (Psyllium husk) ........................45 ANTACIDS Indications: -
Personality and Empathy in Counseling Students a Dissertation
Personality and Empathy in Counseling Students A dissertation presented to the faculty of The Patton College of Education of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Kathleen A. Kutsko May, 2019 © 2019 Kathleen A. Kutsko. All Rights Reserved. 2 This dissertation titled The Relationship Between Personality and Empathy in Counseling Students by KATHLEEN A. KUTSKO has been approved for the Department of Counseling and Higher Education and The Patton College of Education by Yegan Pillay Associate Professor of Counseling and Higher Education Renée A. Middleton Dean, The Patton College of Education 3 Abstract KUTSKO, KATHLEEN A., Ph.D. May 2019, Counselor Education The Relationship Between Personality and Empathy in Counseling Students Director of Dissertation: Yegan Pillay Reports of increased incidences of violence, hate crimes, and discrimination in communities around the globe may be linked to a lack of empathy. Empathy is especially important to cultivate for counselors, as research indicates that empathy is an essential ingredient for developing successful counseling relationships, leading to positive change for clients. The purpose of the present study is to examine the relationship between personality and empathy in a sample of counseling students using the Myers Briggs Type Indicator® as the personality measure and the Interpersonal Reactivity Index as the empathy measure. A series of MANOVAs were conducted with results reporting significant differences in empathy based on personality type. Specifically, the type preferences of Extraversion, Intuition, Feeling, and Perceiving had significantly higher empathy scores than their opposite preferences of Introversion, Sensing, Thinking and Judging, respectively. These findings provide a starting point for future investigations in the areas of personality and empathy in counselor education and supervision programs. -
ENDER's GAME by Orson Scott Card Chapter 1 -- Third
ENDER'S GAME by Orson Scott Card Chapter 1 -- Third "I've watched through his eyes, I've listened through his ears, and tell you he's the one. Or at least as close as we're going to get." "That's what you said about the brother." "The brother tested out impossible. For other reasons. Nothing to do with his ability." "Same with the sister. And there are doubts about him. He's too malleable. Too willing to submerge himself in someone else's will." "Not if the other person is his enemy." "So what do we do? Surround him with enemies all the time?" "If we have to." "I thought you said you liked this kid." "If the buggers get him, they'll make me look like his favorite uncle." "All right. We're saving the world, after all. Take him." *** The monitor lady smiled very nicely and tousled his hair and said, "Andrew, I suppose by now you're just absolutely sick of having that horrid monitor. Well, I have good news for you. That monitor is going to come out today. We're going to just take it right out, and it won't hurt a bit." Ender nodded. It was a lie, of course, that it wouldn't hurt a bit. But since adults always said it when it was going to hurt, he could count on that statement as an accurate prediction of the future. Sometimes lies were more dependable than the truth. "So if you'll just come over here, Andrew, just sit right up here on the examining table. -
Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com Ce4less.Com
Hallucinogens And Dissociative Drug Use And Addiction Introduction Hallucinogens are a diverse group of drugs that cause alterations in perception, thought, or mood. This heterogeneous group has compounds with different chemical structures, different mechanisms of action, and different adverse effects. Despite their description, most hallucinogens do not consistently cause hallucinations. The drugs are more likely to cause changes in mood or in thought than actual hallucinations. Hallucinogenic substances that form naturally have been used worldwide for millennia to induce altered states for religious or spiritual purposes. While these practices still exist, the more common use of hallucinogens today involves the recreational use of synthetic hallucinogens. Hallucinogen And Dissociative Drug Toxicity Hallucinogens comprise a collection of compounds that are used to induce hallucinations or alterations of consciousness. Hallucinogens are drugs that cause alteration of visual, auditory, or tactile perceptions; they are also referred to as a class of drugs that cause alteration of thought and emotion. Hallucinogens disrupt a person’s ability to think and communicate effectively. Hallucinations are defined as false sensations that have no basis in reality: The sensory experience is not actually there. The term “hallucinogen” is slightly misleading because hallucinogens do not consistently cause hallucinations. 1 ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com ce4less.com How hallucinogens cause alterations in a person’s sensory experience is not entirely understood. Hallucinogens work, at least in part, by disrupting communication between neurotransmitter systems throughout the body including those that regulate sleep, hunger, sexual behavior and muscle control. Patients under the influence of hallucinogens may show a wide range of unusual and often sudden, volatile behaviors with the potential to rapidly fluctuate from a relaxed, euphoric state to one of extreme agitation and aggression. -
Pharmacology/Therapeutics II Block I Lectures – 2013‐14
Pharmacology/Therapeutics II Block I Lectures – 2013‐14 54. H2 Blocker, PPls – Patel 55. Principles of Clinical Toxicology – Kennedy 56. Anti‐Parasitic Agents – Johnson (To be posted later) 57. Palliation of Constipation & Nausea/vomiting – Kristopaitis (Lecture in Room 190) Tarun B. Patel, Ph.D Date: January 9, 2013: 10:30 a.m. Reading Assignment: Katzung, Basic and Clinical Pharmacology, 11th Edition, pp. 1067-1077. KEY CONCEPTS AND LEARNING OBJECTIVES Histamine via its different receptors produces a number of physiological and pathological actions. Therefore, anti-histaminergic drugs may be used to treat different conditions. 1. To know the physiological functions of histamine. 2. To understand which histamine receptors mediate the different effects of histamine in stomach ulcers. 3. To know what stimuli cause the release of histamine and acid in stomach. 4. To know the types of histamine H2 receptor antagonists that are available clinically. 5. To know the clinical uses of H2 receptor antagonists. 6. To know the drug interactions associated with the use of H2 receptor antagonists. 7. To understand the mechanism of action of PPIs 8. To know the adverse effects and drugs interactions with PPIs 9. To know the role of H. pylori in gastric ulceration 10. To know the drugs used to treat H. pylori infection Drug List: See Summary Table Provided at end of handout. Page 1 Tarun B. Patel, Ph.D Histamine H2 receptor antagonists and PPIs in the treatment of GI Ulcers: The following section covers medicines used to treat ulcer. These medicines include H2 receptor antagonists, proton pump inhibitors, mucosal protective agents and antibiotics (for treatment of H. -
In the Court of Criminal Appeals of Texas
IN THE COURT OF CRIMINAL APPEALS OF TEXAS NO. AP-76,580 ALBERT JAMES TURNER, Appellant v. THE STATE OF TEXAS ON DIRECT APPEAL FROM CAUSE NO.10-DCR-054233 IN THE 268TH DISTRICT COURT FORT BEND COUNTY KELLER, P.J., delivered the opinion of the Court in which KEASLER, HERVEY, ALCALA, RICHARDSON, YEARY and WALKER., JJ., joined. KEEL., J., dissented. NEWELL, J., did not participate. Appellant was convicted of capital murder for killing his wife and mother-in-law during the same criminal transaction.1 The jury answered the special issues in such a manner that Appellant 1 TEX. PENAL CODE §19.03(a)(7)(A); TEX. CODE CRIM. PROC. art. 37.071. Unless otherwise indicated, all future references to articles refer to the Texas Code of Criminal Procedure. TURNER – 2 was sentenced to death.2 Direct appeal to this Court is automatic.3 On original submission, we remanded this case for a retrospective competency hearing. We later ordered supplemental briefing on the effect, if any, of the Supreme Court’s recent decision in McCoy v. Louisiana.4 We now conclude that Appellant was competent to stand trial, but we also conclude that defense counsel conceded Appellant’s guilt of murder against Appellant’s wishes in violation of McCoy. Consequently, we reverse the trial court’s judgment of conviction and remand the case for a new trial. I. Background The day after Christmas of 2009, Appellant entered the home of his in-laws and killed his wife, Keitha Turner, and his mother-in-law, Betty Jo Frank, by cutting their throats. -
Enhanced Anticoagulation Activity of Functional RNA Origami
bioRxiv preprint doi: https://doi.org/10.1101/2020.09.29.319590; this version posted October 1, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Enhanced Anticoagulation Activity of Functional RNA Origami Abhichart Krissanaprasit, Carson M. Key, Kristen Froehlich, Sahil Pontula, Emily Mihalko, Daniel M. Dupont, Ebbe S. Andersen, Jørgen Kjems, Ashley C. Brown, and Thomas H. LaBean* Dr. A Krissanaprasit, C. M. Key, Prof. T. H. LaBean Department of Materials Science and Engineering, College of Engineering, North Carolina State University, Raleigh, NC, 27695, USA. E-mail: [email protected] K. Froehlich, E. Mihalko, Prof. A. C. Brown Joint Department of Biomedical Engineering, College of Engineering, North Carolina State University and University of North Carolina - Chapel Hill, Raleigh, NC, 27695, USA. S. Pontula William G. Enloe High School, Raleigh, NC 27610, USA Dr. D. M. Dupont, Prof. E. S. Andersen, Prof. J. Kjems Interdisciplinary Nanoscience Center (iNANO), Aarhus University, 8000 Aarhus C, Denmark Prof. A. C. Brown, Prof. T. H. LaBean Comparative Medicine Institute, North Carolina State University and University of North Carolina - Chapel Hill, Raleigh, NC, 27695, USA. Keywords: anticoagulant, RNA origami, nucleic acid, RNA nanotechnology, aptamer, direct thrombin inhibitor, reversal agent 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.29.319590; this version posted October 1, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Anticoagulants are commonly utilized during surgeries and to treat thrombotic diseases like stroke and deep vein thrombosis. -
Treatment for Calcium Channel Blocker Poisoning: a Systematic Review
Clinical Toxicology (2014), 52, 926–944 Copyright © 2014 Informa Healthcare USA, Inc. ISSN: 1556-3650 print / 1556-9519 online DOI: 10.3109/15563650.2014.965827 REVIEW ARTICLE Treatment for calcium channel blocker poisoning: A systematic review M. ST-ONGE , 1,2,3 P.-A. DUB É , 4,5,6 S. GOSSELIN ,7,8,9 C. GUIMONT , 10 J. GODWIN , 1,3 P. M. ARCHAMBAULT , 11,12,13,14 J.-M. CHAUNY , 15,16 A. J. FRENETTE , 15,17 M. DARVEAU , 18 N. LE SAGE , 10,14 J. POITRAS , 11,12 J. PROVENCHER , 19 D. N. JUURLINK , 1,20,21 and R. BLAIS 7 1 Ontario and Manitoba Poison Centre, Toronto, ON, Canada 2 Institute of Medical Science, University of Toronto, Toronto, ON, Canada 3 Department of Clinical Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada 4 Direction of Environmental Health and Toxicology, Institut national de sant é publique du Qu é bec, Qu é bec, QC, Canada 5 Centre Hospitalier Universitaire de Qu é bec, Qu é bec, QC, Canada 6 Faculty of Pharmacy, Université Laval, Qu é bec, QC, Canada 7 Centre antipoison du Qu é bec, Qu é bec, QC, Canada 8 Department of Medicine, McGill University, Montr é al, QC, Canada 9 Toxicology Consulting Service, McGill University Health Centre, Montr é al, QC, Canada 10 Centre Hospitalier Universitaire de Qu é bec, Qu é bec, QC, Canada 11 Centre de sant é et services sociaux Alphonse-Desjardins (CHAU de Lévis), L é vis, QC, Canada 12 Department of Family Medicine and Emergency Medicine, Universit é Laval, Québec, QC, Canada 13 Division de soins intensifs, Universit é Laval, Qu é bec, QC, Canada 14 Populations